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KAJIAN FITOKIMIA TERHADAP  
AKAR SESBANIA GRANDIFLORA DAN SINTESIS  
PEMULA BIOSINTETIK FLAVONOID TERPILIH (TERBITAN KALKON)  
 
ABSTRAK 
 
Sesbania grandiflora, sejenis pokok setinggi 15 m, adalah tumbuhan ubatan 
tradisional yang telah dikutip dari daerah Lampung Selatan, Indonesia. Beberapa 
sebatian baru dan telah dikenal pasti disisihkan dari akar pokok ini. Semua sebatian 
tersebut dikenal pasti sebagai satu sebatian jenis terpenoid, asid betulinik (81), 
sepuluh flavonoid, malindonesianin A-C (82, 86, 88), xenognosin B (83), 
likuiritigenin (84), 7,2’,4’-trihidroksiisoflavon (85), demetilvestitol (87), vestitol 
(89), medikarpin (90), sativan (91), dan satu sebatian jenis biaril, l,l’-binaftalen-2,2’-
diol (92). Tiga sebatian (82, 86, 88) dikenal pasti sebagai dimer isoflavonoid baru, 
manakala satu sebatian (92) dikenali sebagai sebatian semulajadi biaril baru.  
 
Kalkon merupakan pemula biosintetik penting disebabkan kepelbagaian aktiviti 
farmakologinya. Kajian ini bertujuan untuk mensintesis 28 terbitan baru kalkon, 
melalui penggabungan p-alkoksi asetofenon dengan benzaldehid, menggunakan 
alkilasi dan kondensasi Claisen-Schmidt dengan bes sebagai mangkin. Semua 
sebatian terbitan dicirikan dengan menggunakan IR, 1D NMR (1H dan 13C NMR), 
2D NMR (COSY, HMQC, HMBC) dan spektrometri jisim.  
 
 xxix 
Semua sebatian semulajadi dan terbitan baru telah disaring secara in vitro bagi 
mengesan aktiviti antituberkulosis terhadap strain Mycobacterium tuberculosis. Di 
antara sebatian semulajadi, aktiviti antituberkulosis yang ketara terhadap 
Mycobacterium tuberculosis telah ditunjukkan oleh sebatian 92 dengan nilai MIC 
yang terendah iaitu 312.5 x 10-2 µg/mL, manakala antara sebatian terbitan tersebut, 
sebatian 5a, 5b, dan 5d menunjukkan aktiviti antimikrob yang amat baik dengan 
nilai MIC terendah iaitu 12.5 µg/mL. 
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PHYTOCHEMICAL STUDY ON 
 SESBANIA GRANDIFLORA ROOTS AND SYNTHESIS OF  
SELECTED FLAVONOID PRECURSORS 
(CHALCONES DERIVATIVES) 
 
ABSTRACT 
 
Sesbania grandiflora, a small tree up to 15 m tall, is a traditional medicinal plant 
collected from South Lampung, Indonesia. Some new and known compounds were 
isolated from the roots of this plant. They were identified as one terpenoid, betulinic 
acid (81), ten flavonoids, malindonesianin A-C (82, 86, 88), xenognosin B (83), 
liquiritigenin (84), 7,2’,4’-trihydroxyisoflavone (85), demethylvestitol (87), vestitol 
(89), medicarpin (90) and sativan (91), together with one biaryl compound, l,l’-
binaphthalene-2,2’-diol (92). Among them, three compounds (82, 86, 88) were 
established as novel isoflavonoid dimers, while one compound (92) was found as 
new biaryl natural product.  
 
Chalcone is an important biosynthetic precursor, due to the diverse pharmacological 
activities. The aim of this current study was to synthesize 28 new chalcone 
derivatives compounds by incorporating p-alkoxyacetophenones with substituted 
benzaldehydes. Four new series of chalcone derivatives have been synthesized using 
the alkylation and the base catalysed Claisen-Schmidt condensation. All the 
synthesized compounds were fully characterized by IR, 1D NMR (1H and 13C NMR) 
and 2D NMR (COSY, HMQC, HMBC) as well as mass spectrometry analysis.  
 xxxi 
All the isolated and the synthesized compounds were assayed in vitro for their 
antituberculosis activities against Mycobacterium tuberculosis strain. Among 
isolated compounds, significant activity against Mycobacterium tuberculosis was 
exhibited by compound 92 with the lowest MIC value of 312.5 x 10-2 µg/mL, while 
among the synthesized compounds, compounds 5a, 5b, and 5d showed good 
activities with the lowest MIC value of 12.5 µg/mL. 
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CHAPTER ONE 
INTRODUCTION 
 
1.1 General 
The term “natural products’ is generally used to describe a broad collection of the 
chemical compounds or substances produced by a living organism found in nature, 
including plants, animals, marine organisms and microorganism (Bart, 2011). 
Natural products have been exploited by humans as medicine, flavour, poison, food, 
dye and many other uses (Verpoorte, 2007). In recent years, there has been growing 
interest in the therapeutic use of natural products, particularly those derived from 
plants (Chin et al., 2006; Newman & Cragg, 2012). 
 
Plants produce a wide variety of so called secondary metabolites that play an 
important role in producing the medicinal properties and in the survival of the plant 
in its ecosystem. Each plant species has its own specific set of secondary metabolites 
that is usually unique in its structural features (Verpoorte et al., 1999). The well 
known classes secondary metabolites which displayed medicinal properties are 
terpenoids, steroids, alkaloids, and phenolics (Hasan, 2007). 
 
In the past years, there has been a rapidly increasing interest in plant secondary 
metabolites. About more than 100,000 plant secondary metabolites are already 
known, however, only a small percentage of all plants species have been studied for 
their phytopharmacological properties (Verpoorte et al., 2000). Fabaceae plants, 
particularly species in the Papilionoideae subfamily, have long been extensively 
investigated for their phytochemical and pharmacological potentials. Several types of 
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secondary metabolites have been found in this family, including alkaloids, non-
protein amino acids, flavonoids, isoflavonoids, coumarins, phenylpropanoids, 
antraquinones, terpenoids and cyanogenic glycosides (Wink & Mohamed, 2003). 
Among them, isoflavonoids are found predominantly in the Papilionoideae subfamily 
of the Fabaceae. A recent checklist of isoflavonoids reported in the Fabaceae, 
indicates that more than 420 isoflavonoids are new compounds (Veitch, 2007). In 
nature, isoflavonoids provide a wide range of functions, for instance, as 
antimicrobial, anti-insect and allelopathic agents (Dixon & Sumner, 2003), as signal 
molecules for the induction of nod genes (Ferrer et al., 2008; Novák et al., 2004) and 
as pathogen attack inhibitor (Graham & Graham, 2000). Moreover, these compounds 
are well known as common constituents of the human diet (Du et al., 2010). Clinical 
studies on these constituents have suggested a positive effect of isoflavonoids in 
human health and nutrition, such as in preventing heart disease, hormonally 
dependent cancers, menopausal symptoms and osteoporosis (Cogolludo et al., 2007; 
Cornwell et al., 2004; Di et al., 2008; Joung et al., 2003; Kottra & Daniel, 2007; 
Sarkar & Li, 2003).  
 
Due to their significant role in plant defense and health-related benefits, the various 
studies of Fabaceae plant have been conducted, including the isolation and screening 
of biological activity of purified compounds. The biologically active compounds can 
be lead compounds, allowing the design and rational planning of new drugs, the 
synthesis development and the discovery of new therapeutic properties. 
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1.2 Fabaceae 
The Fabaceae is the third largest and one of the most economically important 
families of flowering plants. This family comprises of approximately 19325 species 
in 727 genera and it distributes into three sub-families, including the 
Caesalpinioideae (2250 species), the Mimosoideae (3270 species) and the 
Papilionoideae (13800 species). 
 
Fabaceae is a family of the pea and/or bean plants. They are used as crops, forages, 
and green manures. Their wide variety of natural products lead to the production of 
flavours, drugs, poison, and dyes (Lewis et al., 2005). This large family is also 
known for its variety of compounds, either primary metabolites (lectins, chitinases, 
numerous proteases and α-amylase inhibitors) or secondary metabolites (alkaloids, 
terpenoids, tannins and phenolics compounds) (Carlinia & Grossi-de-Sá, 2002; 
Sotheeswaran & Pasupathy, 1993; Wink & Mohamed, 2003). Among the three 
subfamilies, Papilionoideae is a remarkable chemistry feature of the Fabaceace due 
to the restricted occurrence of isoflavonoids (Veitch, 2009). 
 
Most of the Fabaceae family are frequently used as traditional herbal medicine in the 
treatment of disorders such as diabetes, cough, urinary diseases, eye diseases, lung 
disease, toothache, fever, dysentery and different kinds of infections as well as 
inflammation of skin and mucous membrane (Neto et al., 2008; Roosita et al., 2008; 
Vitor et al., 2004; Watjen et al., 2007).  
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1.3 Sesbania grandiflora (L.) Pers 
Taxonomy Classification 
Kingdom Plantae 
Phylum Magnoliophyta 
Class Magnoliopsida 
Order Fabales 
Family Fabaceae 
Genus Sesbania 
Scientific name Sesbania grandiflora 
Species authority (L.) Pers 
Common names agati, white dragon tree, gauai-gauai, katuday, katurai, pan, 
colbri vegetal, agasti, turi, petai belalang, sesban, sesban 
getih, baculo, agathi, ton kae 
 
 
Sesbania grandiflora (Plates 1.1) is a small erect, quick-growing, and sparsely 
branched tree that reaches up to 10-15 m in height. S. grandiflora is a member of the 
Fabaceae, subfamily Papilionoideae and tribe Robinieae. This plant is native to 
tropical Asia including India, Malaysia, Indonesia, Myanmar and Philippines and is 
found in tropical dry and moist forest from sea level up to 800 m (Heering & 
Gutteridge, 1992). 
  
The tree of S. grandiflora can develop floating roots and aerenchyma tissue. The 
roots are heavily modulated. The leaves (Plates 1.2) are up to 30 cm long including a 
petiole 7-15 mm long and leaflets 20-50, in pairs opposite to alternate on the same 
leaf, oblong to elliptical, 12-44 mm x 5-15 mm, rounded to obtuse to slightly 
emarginated at the apex, glabrous or sparsely pubescent on both surfaces. Stipels 
filiform found in a 0.75 to 1 mm long, pubescent, persistent, and stipules broadly 
lanceolate. The raceme axillary has 2-4 flowers with rachis up to 65 mm long and 
peduncle 15-35 mm long. The flowers (Plates 1.3a) are white, yellowish, rose-pink 
or red with calyx 15-22 mm long. They are closed in young buds, splitting or 
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breaking at anthesis. The basal part persistent in the fruits (Plates 1.3b) are up to 10.5 
x 8 cm and curved for most of its length, ovary and style glabrous. The pods are 
linear to slightly falcate, 20-60 x 6-9 mm with broad sutures, 15-50 seeded, septa 
7.5-10 mm apart, glabrous, hanging vertically and indehiscent (Plates 1.3b).  The 
seeds are dark brown and subreniform, 6.5 x 5 mm x 2.5-3 mm.  The seed weight is 
17,000-30,000 seeds/kg (Heering & Gutteridge, 1992). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plates 1.1 Sesbania grandiflora tree (Heering & Gutteridge, 1992)  
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Plates 1.2 The leaves of S. grandiflora (Gutteridge, 1994)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plates 1.3  The flowers (a), the fruits (b) and the seeds (c) of  
S. grandiflora (Gutteridge, 1994) 
 
  
  
 
(c) 
(b) (a) 
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1.3.1 Medicinal Uses 
All parts of S. grandiflora are traditionally used as medicine in Southeastern Asia 
and India including preparations derived from the roots, bark, gum, leaves, flowers, 
and fruits. Generally, the root is applied as a poultice to relieve from inflammation 
and fever. Ground root of S. grandiflora var. coccinea mixed with water is applied 
externally as a poultice to treat rheumatic swellings. The bark is used as astringent to 
cure smallpox. In Philippines, the decoction from the crushed bark is used for the 
treatment of ulcers in the mouth and alimentary canal. In Java, the local healers use 
the crushed bark for the treatment of thrush and infantile disorders of the stomach, 
and in Cambodia, the pounded bark is applied to treat the scabies. The leaves juice is 
used to treat worms, biliousness, fever, gout, itchiness and leprosy. In Malaysia, the 
crushed leaves are applied to cure sprains and bruises. While in Ayurveda, the leaves 
are employed for the treatment of epileptic fits and the fruits are used for the 
treatment of anaemia, bronchitis, fever and tumors. The leaves and flowers juice is a 
popular remedy for nasal catarrh and headache, head congestion or stuffy nose. The 
flowers juice is dropped into the eyes to correct dim visions (Wagh et al., 2009).  
 
Several studies have been conducted on the extracts obtained from S. grandiflora tree 
for providing a scientific validation of their acclaimed traditional utilisation. A study 
by Fojas et al. (1982) showed that the crude extracts of S. grandiflora possessed a 
hypotensive, oedema and diuretic properties. A study done by Tamboli et al. (2000) 
on three different extracts of S. grandiflora flowers, demonstrated that the ethyl 
acetate extract showed better analgesic and antipyretic activities compared with 
petroleum ether and ethanol extracts. The ethanolic extract of S. grandiflora barks 
displayed antiulcer and anti-inflammatory activities (Serti et al., 2001). Another 
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study done by Kasture et al. (2002) demonstrated that the fraction of S. grandiflora 
leaves exhibited a wide spectrum of anticonvulsant profile and anxiolytic activities. 
Further studies revealed that S. grandiflora leaves could also establish a remarkable 
protective shield against erythromycin estolate-induced hepatotoxicity (Pari & Uma, 
2003). The dichloromethane and methanol extracts of the aerial parts of S. 
grandiflora have also shown to have some antifungal activities (Goun et al., 2003). 
Recently, S. grandiflora leaves supplements have shown to prevent oxidative damage 
in lung, liver and kidney and reverse cigarette smoke-induced oxidative damage in 
rats via its antioxidant potential (Ramesh & Begum, 2006; Ramesh et al., 2007; 
Ramesh et al., 2010). A subsequent research by Doddola et al. (2008) revealed that 
the leaf juice of S. grandiflora exhibits significant antiurolithiatic activity against 
calcium oxalate-type stones as well as antioxidant properties. Besides that, Laladhas 
et al. (2010) had evaluated the flowers of S. grandiflora in vivo and in vitro using 
different cancer cell lines, disclosed that the flowers may serve as a potential 
anticancer drug candidate. Moreover, the n-hexane extract of S. grandiflora seeds 
which was investigated by Shareef et al. (2012), showed that it possessed 
antioxidant, anti-inflammatory, analgesic and antipyretic activities. 
 
1.3.2 Previous Phytochemical Studies on Sesbania grandiflora  
The earliest phytochemical investigation on S. grandiflora started in the 1960s. The 
first simple alcoholic compound, α-5-methyl-5-pentacosanol or grandiflorol 1, was 
isolated from the leaves of S. grandiflora (Tiwari & Bajpai, 1964). Later, Srivastava 
et al. (1968) and Pollard et al. (2011) reported a galactomannan 2 obtained from the 
seeds of S. grandiflora.  
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Das and Tripathi (1998) successfully isolated the first flavonol glycoside from S. 
grandiflora bark, identified as 4'-O-methyl-8-prenylkaempferol-3-O-(α-L-
rhamnosyl-(1→6)-β-D-galactopyranoside)-7-O-β-D-galactopyranoside 3. Further 
study done on the roots of S. grandiflora by Saxena and Mishra (1999a), furnished 
isoflavone glycoside-type flavonoid, 5,7-dihydroxy-6,2'-dimethoxyisoflavone-7-O-α-
L-rhamnopyranoside 4. In addition, another flavone glycoside, 3,7-dihydroxy-8-
methoxyflavone-7-O-β-D-galactoside 5 has been isolated from the stems of              
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S. grandiflora (Saxena & Mishra, 1999b). Furthermore, a triterpenoid, 3-β-hydroxy-
28-p-hydroxyphenoxyolean-12-ene 6 has been isolated from the bark fraction of S. 
grandiflora (Das & Tripathi, 1999).  
 
 
 
 
 
 
Additionally, an analytical study on the gum exudates of S. grandiflora by Anderson 
and Weiping (1990) afforded arabinogalactans with dextrorotatory, acidic and low 
viscosity properties. Recently, Shareef et al. (2012) had studied the sterols profile of 
S. grandiflora oil seeds collected in Pakistan and the results showed the presence of 
significant amount (74.06 %) of β-sitosterol. 
 
1.3.3 Studies on Other Sesbania Species 
The other four species from the genus Sesbania have also been investigated 
phytochemically. From the seeds of S. drummondii, three unusual glutarimide 
compounds, sesbanimide A-C 7-9, were isolated by Powell et al. (1984). These three 
compounds showed inhibitory activity in PS leukimia and KB cell cultures. Later, 
Powell et al. (1990) had re-studied the occurrence of sesbanimide A and its isomers 
in seeds of S. drummondii, S. punicea, S. vesicaria and S. exaltala species, by using a 
tandem mass spectrometric procedure. Wagh et al. (2009) reported that the active 
ingredients of Sesbania were leucocyanidin 10 and cyanidin 11 obtained from the 
seeds, while oleanolic acid 12, its methyl ester 13 and kaempferol-3-rutinoside 14 
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found in the flowers. Recently, three new and six known oleanane saponins 15-23 
have been successfully isolated from the seeds of S. vesicaria (Yuan et al., 2013).  
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1.4 Flavonoids 
Flavonoids are the most ubiquitous polyphenolics in natural products, which are 
derived upon fifteen-carbon skeleton arranged in C6-C3-C6 fashion (Grotewold, 
2006). The two C6 units form aromatic nuclei and the C3 unit links them either to 
form an open chain connection, namely chalcone 24 or to fuse with (ring A), giving 
rise to extra heterocyclic ring (ring C) in flavonoid 25, the so-called 
phenylbenzopyran core (Hasan, 2007). Depending on the position of the linkage 
between the aromatic ring and the benzopyrano (chromano) moiety, flavonoids can 
be divided into three sub-categories, including the flavonoids (2-phenylbenzopyrans) 
25, isoflavonoids (3-benzopyrans) 26, and the neoflavonoids (4-benzopyrans) 27. 
These three groups usually share a common chalcone 24 entity, thus they are 
biogenetically and structurally related (Grotewold, 2006). 
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15 R1 = α-L-Rha-(1→3)-β-D-GlcA, R2 = CH3, R3 = H, R4 = CH2OH 
16 R1 = α-L-Rha, R2 = CHO, R3 = β-D-Glc, R4 = CH3 
17 R1 = α-L-Rha, R2 = CH2OH, R3 = β-D-Glc, R4 = CH3 
18 R1 = β-D-GlcA, R2 = COOH, R3 = β-D-Glc, R4 = CH3 
19 R1 = β-D-GlcA, R2 = CH3, R3 = β-D-Glc, R4 = CH3 
20 R1 = α-L-Rha-(1→3)-β-D-GlcA, R2 = CH3, R3 = β-D-Glc, R4 = CH3 
21 R1 = α-L-Rha-(1→3)-6-OMe-β-D-GlcA, R2 = CH3, R3 = β-D-Glc, R4 = CH3 
22 R1 = β-D-GlcA-(1→2)-[α-L-Rha-(1→3)]-β-D-GlcA, R2 = CH3, R3 = β-D-Glc, R4 = CH3 
23 R1 = β-D-Xyl-(1→2)-[α-L-Rha-(1→3)]-β-D-GlcA, R2 = CH3, R3 = β-D-Glc, R4 = CH3 
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Structural diversification in many types of flavonoids principally emanates from the 
variation in the degree of oxidation and saturation present in the heterocyclic C-ring 
(Grotewold, 2006). In the known type of flavonoids, the range of oxidation level 
extends from highly reduced catechin to highly oxidised flavonol (Fig.1.1).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Biosynthetic origin of flavonoids (Hasan, 2007) 
 
Combination of the shikimate pathway and the acetate-malonate pathway are 
responsible for the biosynthesis of flavonoids. Chalcone is the first flavonoid which 
being formed immediately following the confluence of the two pathways and all 
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other variants of flavonoids are derived from this way by a variety of routes (Hasan, 
2007). Due to a wide variety of flavonoid types, this study is mainly focused on 
chalcones, isoflavonoids and dimer flavonoids which are related with the 
phytochemical and pharmacological investigation on Fabaceae plant.  
 
1.4.1 Chalcones 
Chalcone 24 or 1,3-diaryl-2-propen-1-one is the simplest compound of an open chain 
flavonoids incorporating two aromatic rings through the three-carbon α,β-unsaturated 
carbonyl system. Chalcones are considered to be the minor flavonoids and act as 
precursor for a vast range of flavonoid derivatives found throughout the plant 
kingdom (Grotewold, 2006). These groups of compounds include the 2′-
hydroxychalcones 28, 2′-OH-dihydrochalcones 29, 2′-OH-retro-chalcone 30, aurones 
(2-benzylidenecoumaranone) 31, and auronols 32. It is interesting to note that 
chalcones play an important role in initiating flavonoid biosynthesis as illustrated in 
Fig. 1.2 (Austin & Noel, 2003). In recent years, diverse biological activities 
associated with the chalcone analogues have drawn considerable attention of 
synthetic chemists. The growing number of publications on synthesis and biological 
evaluation of chalcones, demonstrate the growing interest in these compounds and 
their potential use in medicinal chemistry. 
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Figure 1.2  Plant pathways relevant to chalcone synthase (CHS) and resulting classes 
of natural products. (a) The general phenylpropanoid pathway. (b) CHS 
and its importance in flavonoid biosynthesis (Austin & Noel, 2003). 
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1.4.1.1 Biological Activities of Chalcones 
The natural and synthetic chalcone derivatives display a variety of biological 
activities against bacteria, fungi, viruses and tumours. The physiological, 
bacteriostatic and anti-tumour activities of chalcones lead to modification and 
screening of their analogues in search for novel therapeutic agents.  
 
Xanthohumol 33 is the most naturally abundant prenylated chalcone. This compound 
has been isolated from hop cones of Humulus lupulus (Stevens & Page, 2004) and 
showed an interesting spectrum of pharmacological activities, such as apoptotic 
activity against different cell lines, anti-HIV agent, and inhibitor of prostate cancer 
(Colgate et al., 2007; Drenzek et al., 2011; Szliszka et al., 2010; Wang et al., 2004). 
Xanthohumol and its derivatives 34-37 were also successfully synthesised by Vogel 
et al. (2008) and were evaluated the cytotoxicity and anti-oxidative activities. All the 
tested derivatives showed remarkable cytotoxicity and antioxidant properties. 
Additionally, the results indicated that the variation of the hydroxyl group of ring A 
(concerning number and position) in xanthohumol derivatives effected the strength 
of the cytotoxicity in comparison to 33.  
 
 
 
 
 
 
Hamdi et al. (2010), has synthesised a series of chalcone associated with the 
coumarin moiety and screened them against Staphylococcus aureus bacteria. The 
coumarin-chalcone 38 was the most active derivative with IC50 value of 2.07 μM.  
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33 R1 = CH3, R2 = H; R3 = H 
34 R1 = H, R2 = H; R3 = H 
35 R1 = H, R2 = CH3; R3 = H 
36 R1 = CH3, R2 = CH3; R3 = H 
37 R1 = H, R2 = CH3; R3 = CH3 
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The effect of natural or synthetic alkyl chains in these type of compounds has also 
been investigated thoroughly by many researchers (Birnie et al., 2000; Williams et 
al., 2007), due to the ability of lipophilic alkyl chains to disrupt microorganism cell 
wall (Park et al., 2004; Sheu & Freese, 1973).  
 
Recently, the synthesis of hydroxylated chalcone derivatives 39 with variable chain 
length (C6, C10, C12 and C14) by treating benzaldehyde with 4-hydroxyacetophenone 
in the presence of potassium carbonate was investigated by Ngaini et al. (2012). All 
these derivatives were screened for antibacterial activity against Escherichia coli and 
were found to inhibit the growth of this strain in relevant concentrations. The results 
also indicated that the presence of hydroxyl groups at meta position with C6 alkyl 
chains has considerable effect on antimicrobial activities observed.  
 
Mycobacterium tuberculosis is one of the most pathogenic bacterial strains 
responsible for most of the tuberculosis (TB) cases. Among the infectious diseases, 
tuberculosis is the world’s leading cause of death among women of reproductive age 
(Zealand, 1991). Although the improved prevention, detection, diagnosis and 
treatment methods have greatly reduced the affected individuals but the resistance of 
M. tuberculosis against the drug lines, have amplified the incidence of TB 
(Mitchison, 1984). Therefore, there is an urgent need to develop new molecules 
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against this deadly pathogen. The compounds having chalcone moiety and its 
analogues as well as some flavones were evaluated for their activity against M. 
tuberculosis H37Rv (Lin et al., 2002). Among the series of natural chalcones and 
chalcone-like compounds consisting 47 and 21 compounds respectively, two 
chalcones 40, 41 and four chalcone-like compounds 42–45 demonstrated >90% 
inhibitory activity. Furthermore, the results indicated that the substitution of a 
halogen group on the A-ring of 2’-hydroxychalcone improved anti-TB activity, 
whereby halogen-substitution on the 3-position displayed higher anti-TB activity 
than those substituent on 2- or 4-position. Besides, chalcone-like compounds 
demonstrated the most significant anti-TB activity among all the compounds 
evaluated. It was also mentioned that the active compounds in this series might 
require a lipophilic group on one side and a hydrophilic group on the other side of 2-
propen-1-one. 
 
 
 
 
 
 
 
 
1.4.1.2 Methods for The Synthesis of Chalcones 
The synthesis of chalcone derivatives can be carried out via various synthetic 
procedures, including Claisen-Schmidt reaction, Baker-Venkataraman rearrangement 
method, Algar-Flynn-Oyamada and Suzuki coupling reaction. The Claisen–Schmidt 
condensation is a general method to synthesize chalcone derivatives and their 
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analogues, which was used to synthesize novel chalcone derivatives in this study. It 
is a simple, straight-forward and fast procedure to prepare chalcones derivatives, via 
the condensation aromatic aldehydes with acetophenone derivatives in the presence 
of aqueous alkali media (Augustyn et al., 1990). The base-catalyzed Claisen-Schmidt 
condensation have also been attempted by many synthetic chemists to synthesize 
chalcones. Detsi et al. (2009) have successfully synthesised chalcone and aurone 
derivatives with a Claisen-Schmidt reaction between appropriately substituted 2’-
hydroxy-acetophenones and benzaldehydes in basic condition to give 41-88% yield 
of the final product.  
 
 
 
 
 
Scheme 1.1 Synthesis of chalcones derivatives by Claisen–Schmidt condensation 
 
 
1.4.2. Isoflavonoids 
The isoflavonoids are a distinctive subclass of the flavonoids comprising 3-phenyl-
4H-1-benzopyran-4-one (3-phenylchromone) as parent ring system (Grotewold, 
2006). Biogenetically, isoflavonoids are derived from 2-phenylchroman as precursor 
by 1,2-arylmigration to the adjacent carbon of the heterocyclic ring as illustrated in 
Fig.1.3. This arrangement requires NADPH and O2 cofactors to transforms the 
flavanones, liquiritigenin 85 or naringenin 45 into the isoflavones, daidzein 46 or 
genistein 47 via hydroxyisoflavanones intermediate 48 by radical mechanism as 
proposed in Fig. 1.3 (Dewick, 2005). Despite their limited distribution in the plants, 
isoflavonoids are remarkably diverse as far as structural variations are concerned. 
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Their structural diversity arises not only from the number and complexity of 
substituents on the basic 3-phenylchroman system, but also from the different 
oxidation levels and presence of additional heterocyclic rings as well as the 
hydroxylation and alkylation reactions (Grotewold, 2006). 
  
. 
 
 
 
 
 
 
 
Figure 1.3 Proposed biogenetic routes of isoflavonoids (Dewick, 2005)  
 
Isoflavonoids are subdivided into the following groups as described below: 
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1.4.2.1 Naturally Occurring Isoflavonoids 
The discovery of isoflavonoids as natural products has started in the mid-nineteenth 
century. To date, a large number of new and known isoflavonoids has been 
characterized from plants in which the majority of these compounds were isolated 
from the Fabaceae (Dewick, 2005; Veitch, 2007). An elaborated study done by 
Tahara and Ibrahim (1995) on isoflavonoid containing constituents in the root bark 
of Piscidia erythrina, showed unusual isoflavones with a highly substituted B-ring. 
Their exotic structures were established as 4’-amino-5,7,3’-trihydroxy-5’-methoxy-
2’,6’-di-(3,3-dimethylallyl)isoflavone 49, 4’-amino-5,7,3’-trihydroxy-5’-methoxy-
8,2’-di-(3,3-dimethylallyl)isoflavone 50, and 7-hydroxy-5’-methoxy-2’-(3,3-
dimethylallyl)-oxazolo-[4’’’,5’’’:4’,3’]isoflavone 51. It was also reported that these 
compounds were the first naturally occurring flavonoids, directly nitrogenated on the 
C6-C3-C6 skeleton. Later, five highly-prenylated isoflavonoids 52-56 have been 
obtained from the roots of Erythrina zeyhery (Tanaka et al., 2003).  
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Another coumaronochromone-type of isoflavonoids, lespedezol C 57 has been 
successfully isolated for the first time from the stems of Lespedeza homoloba, 
including two geranyl-substituted isoflavones, lespedezol E1 58 and E2 59 (Miyase et 
al., 1999a; Miyase et al., 1999b). Veitch (2007) in his review paper on naturally 
occurring isoflavonoids in Fabaceae plant, reported that 59 is a potential precursor of 
compound 57. Recently, Zappia et al. (2009) have isolated the first isoflavan 
featuring a p-quinol nucleus in the A-ring of isoflavonoid moiety, desmodian D 60, 
together with two new isoflavanones, desmodianone F 61 and desmodianone G 62 
from the roots of Desmodium canum.  
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1.4.2.2 Biological Activities of Isoflavonoids 
Isoflavonoids with their structural diversity, are reported to possess wide range of 
biological activities against different strains of bacteria, fungi, viruses, plasmodium 
and various cancer cell-lines. Kraft and co-workers (2001) have isolated three novel 
2-arylbenzofuran-3-carbaldehydes, andinermals A-C 63-65 by using bioassay-guided 
fractionation of Andira inermis leaves. They found that among the tested compounds, 
compounds 63 and 65 are largely responsible for the antiplasmodial activity shown 
by leaves extract of Andira inermis. A subsequent study (Lo et al., 2002) represented 
some new naturally coumaronochromones-type of isoflavonoids from the roots of 
Euchresta formosana that further evaluated against eight human cancer cells-lines. 
The results indicated that euchretins A 66, J 67 and M 68 showed moderate 
cytotoxicity in a human hepatoma cell line (59T), while compound 67 was found to 
be active against stomach adencarcinoma cell (SCM-1). Moreover, another new 
isoflavone 69 has been obtained from the stems of Derris indica by a group of 
researchers (Koysomboon et al., 2006) and they found that, 69 exhibited the activity 
against Mycobacterium tuberculosis H37Rv. 
 
OO
OH
OCH3
O
OH
OO
OH
O
OH O
OO
OH
OH
OH O
 
61 62 60 
24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.4.3 Flavonoid Dimer 
A literature survey revealed that the main source of flavonoid dimers, heterodimers 
and conjugates are from the genus Dalbergia of Fabaceae plant following by other 
legume genera. A few compounds of this type have also been reported from non-
legumes (Mackova et al., 2006). Basically, dimeric flavonoids can be formed by 
incorporating two monomers of flavonoids with different linkages. 
 
1.4.3.1 Naturally Occurring of Flavonoid Dimers  
To date, the number of new naturally occurring flavonoid dimers is relatively small 
comparing to their monomers and structural diversity of this flavonoids type is 
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